Detalhe da pesquisa
1.
ProvenCare-Psoriasis: A disease management model to optimize care.
Dermatol Online J
; 24(3)2018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29634876
2.
Novel triazolo-pyrrolopyridines as inhibitors of Janus kinase 1.
Bioorg Med Chem Lett
; 23(12): 3592-8, 2013 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23642482
3.
2-Amino-[1,2,4]triazolo[1,5-a]pyridines as JAK2 inhibitors.
Bioorg Med Chem Lett
; 23(17): 5014-21, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23870430
4.
A Review of Therapeutic Escalation for Pediatric Patients Admitted for Inflammatory Bowel Disease Flares.
J Pediatr Pharmacol Ther
; 28(7): 649-657, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38025147
5.
Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2.
Bioorg Med Chem Lett
; 22(24): 7627-33, 2012 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23107482
6.
Pharmacogenomics driven decision support prototype with machine learning: A framework for improving patient care.
Front Big Data
; 5: 1059088, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36458283
7.
A new regulatory switch in a JAK protein kinase.
Proteins
; 79(2): 393-401, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21117080
8.
Pharmacists leadership in a medication shortage response: Illustrative examples from a health system response to the COVID-19 crisis.
J Am Coll Clin Pharm
; 4(9): 1134-1143, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34230910
9.
Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection.
PLoS One
; 16(3): e0243291, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33788846
10.
Dynamic pharmacy leadership during the COVID-19 crisis: Optimizing patient care through formulary and drug shortage management.
Am J Health Syst Pharm
; 77(22): 1874-1884, 2020 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32710774
11.
Clinical Characteristics and Outcomes for 7,995 Patients with SARS-CoV-2 Infection.
medRxiv
; 2020 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32743602
12.
Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA).
Bioorg Med Chem Lett
; 19(19): 5712-5, 2009 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19703768
13.
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S Genotypes.
Clin Pharmacol Ther
; 105(6): 1338-1344, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30499100
14.
Utilizing big data to provide better health at lower cost.
Am J Health Syst Pharm
; 75(7): 427-435, 2018 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29572311
15.
Developing Pharmacogenomic Reports: Insights from Patients and Clinicians.
Clin Transl Sci
; 11(3): 289-295, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29316365
16.
An Integrated Approach to Deploy Panel-Based Pharmacogenetic Testing and Clinical Decision Support.
J Appl Lab Med
; 6(4): 1094-1096, 2021 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125206
17.
Differential inhibition of inducible T cell cytokine secretion by potent iron chelators.
J Biomol Screen
; 10(2): 157-67, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15799959
18.
Multigene predictors of tacrolimus exposure in kidney transplant recipients.
Pharmacogenomics
; 16(8): 841-54, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26067485
19.
Identification of C-2 hydroxyethyl imidazopyrrolopyridines as potent JAK1 inhibitors with favorable physicochemical properties and high selectivity over JAK2.
J Med Chem
; 56(11): 4764-85, 2013 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23659214
20.
Potent and selective aminopyrimidine-based B-Raf inhibitors with favorable physicochemical and pharmacokinetic properties.
J Med Chem
; 55(6): 2869-81, 2012 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22335519